Local regulatory expertise across CEE and Emerging markets. Learn More
Placing biocidal products on the market requires more than understanding the applicable legislation. It requires knowing which regulatory pathway is available, how the relevant authority applies the rules in practice, and how to prepare a submission that meets both legal and country-specific expectations.
At Artemisa, we support manufacturers and distributors with biocide registrations across CEE and neighbouring markets, including Albania, Armenia, Azerbaijan, Bosnia and Herzegovina, Egypt, Georgia, Kazakhstan, Kosovo, Moldova, Montenegro, North Macedonia, Serbia, Türkiye, Ukraine and Uzbekistan.
Our strength lies in combining EU regulatory knowledge with local expertise and practical execution in individual markets. Whether your product falls under the EU Biocidal Products Regulation, national transitional measures, or a country-specific national procedure outside the EU, we help you identify the right pathway and manage the process from strategy to submission and follow-up.
Every successful registration starts with choosing the right regulatory pathway. We help you assess the most suitable route based on your product, active substance, intended use, target countries and commercial objectives.
Our services include:
Biocidal products in the EU are regulated under Regulation (EU) No. 528/2012, known as the Biocidal Products Regulation (BPR). Depending on the product, active substance status, product type and intended markets, different regulatory procedures may be available, including:
Where transitional measures remain applicable, national procedures may still provide an important route to market. These procedures are not harmonised and can differ significantly between countries. Requirements, documentation, language, timelines and authority expectations may vary from one market to another.
We help you:
Outside the EU, biocidal products are subject to national regulatory frameworks that may differ substantially from the EU BPR. These markets can offer important commercial opportunities, but they often require a different regulatory approach. Product status, registration procedures, data requirements, documentation, labelling and authority practices need to be assessed according to the individual market.
Depending on the country, the regulatory process may involve:
A national SPC or product label is not only a translation exercise. It requires regulatory understanding, correct terminology and adaptation to national requirements and authority expectations.
Our native-speaking experts prepare and review SPCs and labels in multiple national languages, helping ensure that the content is both linguistically accurate and regulatory appropriate.
We can support:
Submission is only one part of the registration process. The quality and efficiency of post-submission communication can have an important influence on the progress of a regulatory procedure.
We support clients with:
Managing biocide registrations in several countries can quickly become complex, particularly when EU and non-EU markets are involved. Artemisa provides one dedicated project manager who coordinates the work across countries and keeps the process organised.
Your project manager will:
The appropriate regulatory pathway depends on several factors, including the product, active substance status, product type, intended uses, existing authorisations and target markets.
Depending on these factors, different procedures may be available under the EU BPR or, where applicable, under national transitional arrangements. Outside the EU, country-specific national procedures apply.
Artemisa can assess the available options and help identify the most appropriate regulatory strategy for your target markets.
Yes. Under Regulation (EU) No 528/2012, Mutual Recognition provides a pathway for seeking authorisation of a biocidal product in additional EU Member States, subject to the applicable BPR requirements.
Depending on the registration strategy, Mutual Recognition may be pursued in Sequence or in Parallel.
Artemisa can coordinate Mutual Recognition procedures across several target countries, including country-specific documentation, SPC and label adaptation, submissions, authority communication and follow-up.
Depending on the status of the relevant active substance/product-type combination, national transitional provisions may continue to apply.
As these requirements are not harmonised, the applicable procedure and requirements should be assessed individually for each target country.
No. National transitional procedures, documentation requirements, language requirements, timelines and authority practices can differ between Member States.
This is one of the areas where local regulatory knowledge is particularly valuable.
The Summary of Product Characteristics (SPC) is an important part of a biocidal product authorisation and defines key authorised conditions relating to the product and its use.
SPCs may need to be prepared or adapted as part of national and multi-country procedures. Artemisa supports both the regulatory and linguistic aspects of SPC preparation.
Article 95 of the BPR establishes requirements relating to suppliers of active substances and biocidal products. Compliance should be considered as part of the regulatory assessment before placing relevant biocidal products on the EU market.
Artemisa can review Article 95 status as part of the initial regulatory assessment.
Yes. Artemisa provides regulatory support for biocidal products in selected non-EU markets.
Because regulatory systems outside the EU may differ substantially from the BPR, we assess the applicable national requirements and can support regulatory strategy, documentation, national applications, authority communication and follow-up throughout the registration process.
Yes. Artemisa can centrally coordinate multi-country projects while involving local regulatory experts in each target market.
This provides clients with one dedicated contact and central project management while ensuring that country-specific requirements are addressed locally.
Even where a common EU regulatory framework applies, practical implementation, national administrative requirements and authority communication may differ between countries.
For transitional procedures and non-EU markets, these differences can be even greater.
Our local experts understand not only the applicable regulatory requirements, but also how procedures are managed in practice in their respective markets.